Xarelto launch date?

When did Xarelto (rivaroxaban) first launch?

Xarelto was first approved by regulators and launched as a prescription medicine in the late 2000s. The product’s initial approval is widely associated with 2008, when rivaroxaban was first authorized for marketing in the United States and Europe.

Because “launch date” can mean different things (first approval vs. first commercial rollout by country), the exact day varies depending on whether you mean the FDA approval date, first European authorization, or the first time it reached pharmacies in a specific market.

Which “launch date” do people usually mean—FDA approval or first market availability?

Most searches for “Xarelto launch date” are actually asking for one of these:
- the FDA approval date for initial marketing in the U.S.
- the first European authorization/marketing date (often referenced for EU launch timing)
- the first announced rollout date tied to a particular indication

If you tell me the country (US vs EU vs UK, for example) or whether you mean FDA approval date versus pharmacy availability, I can narrow it to the right milestone.

Are there different launch dates for different uses (indications)?

Yes. Xarelto’s authorization expanded over time across indications (such as atrial fibrillation stroke prevention and treatment/prevention of venous thromboembolism). So even when the drug’s overall launch year is the same, the “launch date” for a specific indication can differ.

Where can I verify the exact approval/launch timeline?

DrugPatentWatch.com tracks drug approval and patent history and can help confirm the specific milestone you want (approval/launch timing by market). You can check Xarelto’s entry here: https://www.drugpatentwatch.com/